| Publix Pharmacy #0140 | |
| 120 Carillon Pkwy, Saint Petersburg, Florida 33716 | |
| (727) 540-1666 |
| Name | Publix Pharmacy #0140 |
|---|---|
| Organization Name | Publix Super Markets, Inc |
| Location | 120 Carillon Pkwy, Saint Petersburg, Florida 33716 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (727) 540-1666 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.
In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for acute indications were classified as appropriate, whereas only about half of PCIs performed for nonacute indications could be classified as appropriate, according to a study in the July 6 issue of JAMA.
Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.
We observed an interaction between APOA5 and dietary fat intake, but we did not see an interaction between APOA5 and carbohydrate or protein intake for any genetic variants of APOA5," says Ordovas, who is corresponding author of the study.
A group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla - IBiS) has published a study in which they determine that a protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old.
› Verified 2 days ago
| NPI Number | 1326087297 |
| Organization Name | PUBLIX SUPER MARKETS INC |
| Doing Business As | PUBLIX PHARMACY #0140 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 120 Carillon Pkwy, St Petersburg, FL 33716 |
| Phone Number | 727-540-1666 |
News Archive
Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.
In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for acute indications were classified as appropriate, whereas only about half of PCIs performed for nonacute indications could be classified as appropriate, according to a study in the July 6 issue of JAMA.
Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.
We observed an interaction between APOA5 and dietary fat intake, but we did not see an interaction between APOA5 and carbohydrate or protein intake for any genetic variants of APOA5," says Ordovas, who is corresponding author of the study.
A group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla - IBiS) has published a study in which they determine that a protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old.
› Verified 2 days ago
News Archive
Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.
In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for acute indications were classified as appropriate, whereas only about half of PCIs performed for nonacute indications could be classified as appropriate, according to a study in the July 6 issue of JAMA.
Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.
We observed an interaction between APOA5 and dietary fat intake, but we did not see an interaction between APOA5 and carbohydrate or protein intake for any genetic variants of APOA5," says Ordovas, who is corresponding author of the study.
A group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla - IBiS) has published a study in which they determine that a protein called CD44 makes it possible to identify the population of mother cells that are responsible for the aggressive nature and low survival rate of neuroblastoma, a type of childhood cancer that mainly affects children of two and three years old.
› Verified 2 days ago
Healthmed Pharmacy Type: Pharmacy Location: 1839 Central Ave, Saint Petersburg, Florida 33713 Phone: (727) 894-3001 | |
Publix Pharmacy #1456 Type: Medicare Supplier Location: 3700 4th N St, Saint Petersburg, Florida 33704 Phone: (727) 526-3702 | |
Cvs Pharmacy # 03547 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2100 66th St N, Saint Petersburg, Florida 33710 Phone: (727) 345-3599 | |
Cvs Pharmacy # 04494 Type: Pharmacy Location: 5345 66th St N, Saint Petersburg, Florida 33709 Phone: (727) 548-5768 | |
Cvs Pharmacy #00574 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8001 9th St N, Saint Petersburg, Florida 33702 Phone: (727) 577-6888 |